INBS (Intelligent Bio Solutions) LT-Debt-to-Total-Asset: 0.10 (As of Mar. 2026)

What is Intelligent Bio Solutions LT-Debt-to-Total-Asset?

Intelligent Bio Solutions INBS +0.45% 44 LT-Debt-to-Total-Asset is 0.10 as of Mar. 2026. GuruFocus rates INBS with a GF Score™ of 44/100 and a GF Value™ of $3.93 (Possible Value Trap). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Intelligent Bio Solutions's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.10.

Intelligent Bio Solutions's long-term debt to total assets ratio increased from Mar. 2025 (0.00) to Mar. 2026 (0.10). It may suggest that Intelligent Bio Solutions is progressively becoming more dependent on debt to grow their business.

Intelligent Bio Solutions (NAS:INBS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Intelligent Bio Solutions LT-Debt-to-Total-Asset Related Terms

Intelligent Bio Solutions LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Intelligent Bio Solutions's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Bio Solutions LT-Debt-to-Total-Asset Chart

Intelligent Bio Solutions Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

0.07

0.01

0.00

Intelligent Bio Solutions Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.00	0.14	0.09	0.10

44GF Score

Intelligent Bio Solutions Inc INBS

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Intelligent Bio Solutions LT-Debt-to-Total-Asset Calculation

Intelligent Bio Solutions's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as

LT Debt to Total Assets (A: Jun. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2025 )	/	Total Assets (A: Jun. 2025 )
	=	0	/	8.25
	=	0.00

Intelligent Bio Solutions's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	1.46	/	14.863
	=	0.10

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.10 mean?

Intelligent Bio Solutions (INBS) has a LT-Debt-to-Total-Asset of 0.10 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Intelligent Bio Solutions and its competitors.

Is Intelligent Bio Solutions' LT-Debt-to-Total-Asset too high?

Intelligent Bio Solutions' current LT-Debt-to-Total-Asset is 0.10. Overall, Intelligent Bio Solutions has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Intelligent Bio Solutions' LT-Debt-to-Total-Asset compare to ITOC and WOK?

Intelligent Bio Solutions' LT-Debt-to-Total-Asset of 0.10 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Intelligent Bio Solutions and its competitors. Intelligent Bio Solutions's current LT-Debt-to-Total-Asset is 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Intelligent Bio Solutions stock overvalued right now?

Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.93, compared to a current price of $2.24 — trading 43% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.10. Intelligent Bio Solutions' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current LT-Debt-to-Total-Asset is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.24 is trading 43% below its estimated GF Value™ of $3.93. GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.

Key valuation signals for INBS:

LT-Debt-to-Total-Asset: 0.10
GF Value™: $3.93 vs. price of $2.24 (43% below fair value)
GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies ITOC WOK BMRA POAS TNON XAIR VVOS IVF RMSL ADMT ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036

Website https://www.ibs.inc

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

44GF Score

Get the complete analysis for INBS

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24

Price

$3.93

GF Value

View INBS Analysis

See LT-Debt-to-Total-Asset data for all stocks →